New York · 2025 Regular Session · Bill

A 500: Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative

In committee Last action January 7, 2026: REFERRED TO HEALTH

Plain-language summary

A 500 is a bill introduced in the New York House on January 8, 2025. According to its official title, it concerns: Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative. Primary sponsor: Phil Steck (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.

Sponsors

Primary sponsor: Phil Steck (Democratic).